Kiromic BioPharma Inc (KRBP)
3.20
-0.02
(-0.62%)
USD |
OTCM |
May 24, 16:00
Kiromic BioPharma Total Liabilities (Quarterly): 19.84M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.84M |
| December 31, 2023 | 21.29M |
| September 30, 2023 | 18.72M |
| June 30, 2023 | 19.93M |
| March 31, 2023 | 21.25M |
| December 31, 2022 | 17.74M |
| September 30, 2022 | 12.74M |
| June 30, 2022 | 7.739M |
| March 31, 2022 | 5.858M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.410M |
| September 30, 2021 | 1.445M |
| June 30, 2021 | 1.567M |
| March 31, 2021 | 1.700M |
| December 31, 2020 | 1.468M |
| September 30, 2020 | 2.252M |
| June 30, 2020 | 1.786M |
| March 31, 2020 | 0.8867M |
| December 31, 2019 | 0.6737M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6737M
Minimum
Dec 2019
21.29M
Maximum
Dec 2023
8.905M
Average
4.634M
Median
Total Liabilities (Quarterly) Benchmarks
| Lisata Therapeutics Inc | 5.497M |
| Achieve Life Sciences Inc | 20.57M |
| Syra Health Corp | 1.102M |
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.63M |
| Shareholders Equity (Quarterly) | -7.212M |